This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Kurt Vagle
Senior Director - Chemical Development RNAi CMC at Novo Nordisk
Speaker

Profile

Senior Director at Novo Nordisk, leads chemical development for oligonucleotide therapeutics, specializing in oligonucleotide manufacturing, phosphoramidite scale‑up, and sustainable oligonucleotide synthesis strategies. Kurt has spent his 30-year career in the field of modified nucleoside and oligonucleotide chemistry.

Agenda Sessions

  • New SPOS Support to Drive Next Generation Manufacturing

    , 2:30pm
    View Session

At this event

Prev
Next
Marc Abrams, PhD
Chief Technology Officer & Head, US Operations
SanegeneBio

See Kurt at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now